The endogenous toxin hypothesis of the etiology of Parkinson's disease and a pilot trial of high-dosage antioxidants in an attempt to slow the progression of the illness.
Fahn
S
S
Department of Neurology, Columbia University College of Physicians and Surgeons, New York, New York 10032.
D000328:Adult; D000368:Aged; D000375:Aging; D000975:Antioxidants; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D002452:Cell Count; D005260:Female; D005609:Free Radicals; D006801:Humans; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D000975:Antioxidants; D005609:Free Radicals; D014810:Vitamin E; D001205:Ascorbic Acid